These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11641422)

  • 1. Identification of essential residues involved in the glutamate binding pocket of the group II metabotropic glutamate receptor.
    Malherbe P; Knoflach F; Broger C; Ohresser S; Kratzeisen C; Adam G; Stadler H; Kemp JA; Mutel V
    Mol Pharmacol; 2001 Nov; 60(5):944-54. PubMed ID: 11641422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.
    Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S
    Neuropharmacology; 2016 Dec; 111():253-265. PubMed ID: 27590915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.
    Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S
    Neuropharmacology; 2017 Mar; 115():115-127. PubMed ID: 28216000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of [(3)H]-LY354740 binding to rat mGlu2 and mGlu3 receptors expressed in CHO cells using semliki forest virus vectors.
    Schweitzer C; Kratzeisen C; Adam G; Lundstrom K; Malherbe P; Ohresser S; Stadler H; Wichmann J; Woltering T; Mutel V
    Neuropharmacology; 2000 Jul; 39(10):1700-6. PubMed ID: 10884552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
    Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
    J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and abundance of metabotropic glutamate receptor subtype 2 in rat brain revealed by [3H]LY354740 binding in vitro and quantitative radioautography: correlation with the sites of synthesis, expression, and agonist stimulation of [35S]GTPgammas binding.
    Richards G; Messer J; Malherbe P; Pink R; Brockhaus M; Stadler H; Wichmann J; Schaffhauser H; Mutel V
    J Comp Neurol; 2005 Jun; 487(1):15-27. PubMed ID: 15861463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice.
    Linden AM; Shannon H; Baez M; Yu JL; Koester A; Schoepp DD
    Psychopharmacology (Berl); 2005 Apr; 179(1):284-91. PubMed ID: 15619115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenesis and molecular modeling of the orthosteric binding site of the mGlu2 receptor determining interactions of the group II receptor antagonist (3)H-HYDIA.
    Lundström L; Kuhn B; Beck J; Borroni E; Wettstein JG; Woltering TJ; Gatti S
    ChemMedChem; 2009 Jul; 4(7):1086-94. PubMed ID: 19402024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039).
    Rorick-Kehn LM; Johnson BG; Burkey JL; Wright RA; Calligaro DO; Marek GJ; Nisenbaum ES; Catlow JT; Kingston AE; Giera DD; Herin MF; Monn JA; McKinzie DL; Schoepp DD
    J Pharmacol Exp Ther; 2007 Apr; 321(1):308-17. PubMed ID: 17204749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro binding characteristics of a new selective group II metabotropic glutamate receptor radioligand, [3H]LY354740, in rat brain.
    Schaffhauser H; Richards JG; Cartmell J; Chaboz S; Kemp JA; Klingelschmidt A; Messer J; Stadler H; Woltering T; Mutel V
    Mol Pharmacol; 1998 Feb; 53(2):228-33. PubMed ID: 9463480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors.
    Schoepp DD; Johnson BG; Wright RA; Salhoff CR; Mayne NG; Wu S; Cockerman SL; Burnett JP; Belegaje R; Bleakman D; Monn JA
    Neuropharmacology; 1997 Jan; 36(1):1-11. PubMed ID: 9144636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural determinants of allosteric antagonism at metabotropic glutamate receptor 2: mechanistic studies with new potent negative allosteric modulators.
    Lundström L; Bissantz C; Beck J; Wettstein JG; Woltering TJ; Wichmann J; Gatti S
    Br J Pharmacol; 2011 Sep; 164(2b):521-37. PubMed ID: 21470207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational Pharmacology of the Metabotropic Glutamate 2 Receptor-Preferring Agonist LY2812223 in the Animal and Human Brain.
    Felder CC; Schober DA; Tu Y; Quets A; Xiao H; Watt M; Siuda E; Nisenbaum E; Xiang C; Heinz B; Prieto L; McKinzie DL; Monn JA
    J Pharmacol Exp Ther; 2017 Apr; 361(1):190-197. PubMed ID: 28138041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Pharmacological Characterization of C4
    Monn JA; Henry SS; Massey SM; Clawson DK; Chen Q; Diseroad BA; Bhardwaj RM; Atwell S; Lu F; Wang J; Russell M; Heinz BA; Wang XS; Carter JH; Getman BG; Adragni K; Broad LM; Sanger HE; Ursu D; Catlow JT; Swanson S; Johnson BG; Shaw DB; McKinzie DL; Hao J
    J Med Chem; 2018 Mar; 61(6):2303-2328. PubMed ID: 29350927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional coupling between metabotropic glutamate receptors and G-proteins in rat cerebral cortex assessed by guanosine-5'-O-(3-[(35)S]thio)triphosphate binding assay.
    Odagaki Y; Kinoshita M; Toyoshima R
    Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):175-85. PubMed ID: 21443596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Arg(78) in the metabotropic glutamate receptor mGlu(1) for agonist binding and selectivity.
    Jensen AA; Sheppard PO; O'Hara PJ; Krogsgaard-Larsen P; Bräuner-Osborne H
    Eur J Pharmacol; 2000 Jun; 397(2-3):247-53. PubMed ID: 10844121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of allosteric modulation: Exploring the binding kinetics of glutamate and other orthosteric ligands of the metabotropic glutamate receptor 2.
    Doornbos MLJ; Vermond SC; Lavreysen H; Tresadern G; IJzerman AP; Heitman LH
    Biochem Pharmacol; 2018 Sep; 155():356-365. PubMed ID: 30028996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex.
    Marek GJ; Wright RA; Schoepp DD; Monn JA; Aghajanian GK
    J Pharmacol Exp Ther; 2000 Jan; 292(1):76-87. PubMed ID: 10604933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
    Cartmell J; Monn JA; Schoepp DD
    J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabotropic glutamate group II receptors activate a G protein-coupled inwardly rectifying K+ current in neurones of the rat cerebellum.
    Knoflach F; Kemp JA
    J Physiol; 1998 Jun; 509 ( Pt 2)(Pt 2):347-54. PubMed ID: 9575285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.